Literature DB >> 2615522

Chronic leukaemia: an African experience.

C C Okany1, O O Akinyanju.   

Abstract

One hundred and eighteen patients with chronic leukaemias were seen at the Lagos University Teaching Hospital, Nigeria, between 1964 and 1982. There were 75 patients with chronic granulocytic leukaemia (CGL) and 43 patients with chronic lymphocytic leukaemia (CLL). Although most of them presented with the familiar features of chronic leukaemias, a few features were remarkably different from those reported in some of the Caucasian series. CLL is less common than CGL in contrast to their relative incidence in Caucasians. Our patients generally presented with more massive splenomegaly and more severe anaemia, which could be attributed to late presentation, endemic malaria and possibly increased hypersplenism. The peak-age incidence in our patients with CGL was found in a younger age group (20-40 yr) than in the Caucasian series. When compared with a Caucasian series, our CGL patients on presentation had a significantly higher proportion of immature cells (blasts and promyelocytes) (P less than 0.05), probably reflecting their more delayed presentation. Follow up was generally poor as a result of a high default rate. Survival duration of both leukaemias was generally lower than in Caucasian series and for CGL patients there was a significant negative correlation between survival and spleen size at presentation, while for CLL patients there was a significant association between poor survival duration and high white cell count at presentation.

Entities:  

Mesh:

Year:  1989        PMID: 2615522     DOI: 10.1007/bf02985189

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  10 in total

1.  Incidence of leukaemia in Singapore, and rarity of chronic lymphocytic leukaemia in Chinese.

Authors:  R WELLS; K S LAU
Journal:  Br Med J       Date:  1960-03-12

2.  Radioactive phosphorus. II. In the treatment of myeloid leukemia.

Authors:  H D DIAMOND; L F CRAVER
Journal:  Cancer       Date:  1951-09       Impact factor: 6.860

3.  Myelocytic leukemia: an analysis of incidence, distribution and fatality, 1910-1948.

Authors:  M B SHIMKIN; S R METTIER; H R BIERMAN
Journal:  Ann Intern Med       Date:  1951-07       Impact factor: 25.391

4.  The clinical features of chronic granulocytic leukaemia.

Authors:  A S Spiers
Journal:  Clin Haematol       Date:  1977-02

Review 5.  The clinical features of chronic lymphocytic leukaemia.

Authors:  D L Sweet; H M Golomb; J E Ultmann
Journal:  Clin Haematol       Date:  1977-02

Review 6.  Unfavorable signs in patients with chronic myelocytic leukemia.

Authors:  A Theologides
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

Review 7.  Chronic myelogenous leukemia--new concepts (first of two parts).

Authors:  H P Koeffler; D W Golde
Journal:  N Engl J Med       Date:  1981-05-14       Impact factor: 91.245

8.  Suppression of malaria with pyrimethamine in Nigerian schoolchildren.

Authors:  H M ARCHIBALD; L J BRUCE-CHWATT
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

9.  Leukaemia in Nigerians: the chronic leukaemias.

Authors:  E M Essien
Journal:  East Afr Med J       Date:  1976-02

10.  The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases.

Authors:  A S Spiers; B J Bain; J E Turner
Journal:  Scand J Haematol       Date:  1977-01
  10 in total
  3 in total

1.  Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls.

Authors:  Abayomi O Bamgboje; Muheez A Durosinmi; Tuoyo O Mene-Afejuku; Micheal O Fagbayimu; Olusola Fajobi; Michael O Balogun
Journal:  Vasc Health Risk Manag       Date:  2022-02-15

2.  The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire.

Authors:  K G Koffi; D C Nanho; E N'dathz; P Kouehion; R Dissieka; A Attia; K Mozard; A Tolo; K Boidy; N Meité; R Ayemou; M Sekongo; N Tea; I Sanogo
Journal:  Adv Hematol       Date:  2010-08-25

3.  Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia.

Authors:  Anthony A Oyekunle; Rahman A Bolarinwa; Adesola T Oyelese; Lateef Salawu; Muheez A Durosinmi
Journal:  Adv Hematol       Date:  2015-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.